August 8, 2022 by Chain Drug Review
President Biden, Senate
Business, Leading Headlines, Pharmacy
WASHINGTON – The U.S. Senate passed on Sunday a sweeping $430 billion bill intended to fight climate change, lower drug prices and raise some corporate taxes, a major victory for President Joe Biden that Democrats hope will aid their chances of keeping control of Congress in this year’s elections. After a marathon, 27-hour weekend session
May 22, 2022 by Chain Drug Review
President Biden
Leading Headlines, Supplier News
WASHINGTON — President Biden is announcing the first two Defense Production Act (DPA) authorizations for infant formula. U.S. Department of Health and Human Services Secretary Xavier Becerra authorized the first two infant formula priority orders today. The two infant formula manufacturers can now begin to add legally binding language to their orders with suppliers that
January 13, 2022 by Chain Drug Review
COVID-19, President Biden
Leading Headlines
WASHINGTON — President Biden announced Thursday that the government will double to 1 billion the rapid, at-home COVID-19 tests to be distributed free to Americans, along with “high-quality masks,” as he highlighted his efforts to “surge” resources to help the country weather the spike in coronavirus cases. Biden also announced that starting next week 1,000
December 21, 2021 by Chain Drug Review
COVID-19 at home testing, President Biden
Leading Headlines, Pharmacy
WASHINGTON — President Biden announced on Tuesday a new plan to distribute 500 million free at-home rapid tests to Americans beginning in January as part of an attempt to double down on the spread of a transmissible variant that has hit the U.S. distressingly close to the holidays. “I want to start by acknowledging how
June 2, 2021 by Chain Drug Review
COVID-19 vaccines in pharmacies, President Biden
Leading Headlines, Pharmacy
WASHINGTON —President Biden on Wednesday declared June a “national month of action” to mobilize even more Americans to get vaccinated by July Fourth, in order to enjoy what he called “a summer of freedom.” The president is urging Americans who haven’t yet gotten vaccinated to get the COVID-19 shot, rolling out new incentives by the
May 14, 2021 by Chain Drug Review
NACDS, President Biden
Leading Headlines, Pharmacy
WASHINGTON— During his remarks on Wednesday, May 12, regarding the COVID-19 response and the vaccination program, President Joe Biden underscored the unique convenience and accessibility of community pharmacies nationwide, noting that more than 15,000 pharmacies are prepared to vaccinate adolescents ages 12-15. President Biden’s comments follow the Centers for Disease Control and Prevention’s (CDC) Advisory
April 29, 2021 by Chain Drug Review
President Biden
Leading Headlines
WASHINGTON — President Joe Biden noted Wednesday night that 40,000 pharmacies have helped administer over 220 million COVID-19 vaccinations in his first 100 days in office. “We’re marshalling every federal resource,” Biden said in an address to a joint session of Congress. “Ninety percent of Americans now live within 5 miles of a vaccination site.”
April 13, 2021 by Chain Drug Review
Barack Obama, President Biden, Roll Up Your Sleeves, Walgreens
Leading Headlines, Retail News
NEW YORK – President Biden and Barack Obama will be among the guests on NBC’s “Roll Up Your Sleeves” vaccination special airing Sunday, April 18 at 7 p.m. ET/PT. Presented by Walgreens and created by ATTN: in partnership with Civic Nation’s Made to Save initiative, the hour-long program aims to educate viewers, raise awareness and
March 29, 2021 by Chain Drug Review
NACDS, NACDS president and chief executive officer Steven Anderson, President Biden
Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS president and CEO Steven Anderson issued the following statement today. His comments follow President Joe Biden’s March 29 announcement regarding the expansion of the Federal Retail Pharmacy Program: “Our nation’s pharmacies are uniquely situated to turn vaccine doses into vaccination appointments – efficiently, equitably and conveniently. We appreciate President Biden’s leadership
March 25, 2021 by Chain Drug Review
COVID-19 vaccines, President Biden
Leading Headlines, Pharmacy
WASHINGTON — President Joe Biden announced on Thursday a new major goal of having 200 million COVID-19 vaccination shots being administered within his first 100 days in office. “I know it’s ambitious — twice our original goal — but no other country in the world has come close … to what we’re doing,” Biden said
March 12, 2021 by Chain Drug Review
CVS Health, Karen Lynch, President Biden
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — The following is attributed to Karen S. Lynch, president and chief executive officer, CVS Health: “President Biden’s decision to double the number of participants in the Federal Retail Pharmacy Program is a testament to its success, and an acknowledgment that pharmacies will continue to be one of the most convenient vaccine access
March 10, 2021 by Chain Drug Review
$1.9 trillion COVID-19 relief bill, House, President Biden, The American Rescue Plan
Leading Headlines
WASHINGTON — House Democrats on Wednesday passed the $1.9 trillion COVID-19 relief bill with the ultimate goal of having it on President Joe Biden’s desk by Friday, just days before key federal unemployment benefits start to expire for many workers on March 14. By a 220-211 vote, with no Republicans voting yes, Democrats handed Biden
March 6, 2021 by Chain Drug Review
President Biden
Leading Headlines
WASHINGTON – The Democratic-controlled Senate Saturday passed President Joe Biden’s $1.9 trillion COVID-19 relief package which would provide millions of Americans with $1,400 direct payments, billions of dollars for vaccine distribution, and funds to help reopen schools and colleges. The chamber passed the bill following a session that began around 9 a.m. Friday and ended at
March 2, 2021 by Chain Drug Review
Johnson & Johnson vaccine, Merck, President Biden
Featured Articles, Leading Headlines, Pharmacy
WASHINGTON — Merck will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, the White House reported Tuesday. This announcement comes as the White House looks to ramp up the production of the single-dose vaccine. Officials have said J&J faced unexpected production issues with its vaccine